Palbociclib and Pembrolizumab in Sarcoma
Clinical trial NCT06113809 · RECRUITING
Trial details
- NCT number
- NCT06113809
- Sponsor
- John Rieth
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2028-07-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.